Abstract
This chapter examines various methods of comparing, combining and converting various screening instruments. Methods of comparing cognitive scales include not only the standard measures of discrimination considered in previous chapters but also weighted comparison and effect size, as well as meta-analysis. The diagnostic utility of combinations of scales, both cognitive and non-cognitive, is also considered, as well as ways to make approximate conversions between the scores of different screening tests.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Aziz K, Larner AJ. Six-item Cognitive Impairment Test (6CIT): pragmatic diagnostic accuracy study for dementia and MCI. Int Psychogeriatr. 2015;27:991–7.
Abreu ID, Nunes PV, Diniz BS, Forlenza OV. Combining functional scales and cognitive tests in screening for mild cognitive impairment at a university-based memory clinic in Brazil. Rev Bras Psiquiatr. 2008;30:346–9.
Alexopoulos P, Ebert A, Richter-Schmidinger T, et al. Validation of the German revised Addenbrooke’s cognitive examination for detecting mild cognitive impairment, mild dementia in Alzheimer’s disease and frontotemporal lobar degeneration. Dement Geriatr Cogn Disord. 2010;29:448–56.
Ashford JW. Screening for memory disorders, dementia and Alzheimer’s disease. Aging Health. 2008;4:399–432.
Barberger-Gateau P, Commenges D, Gagnon M, Letenneur L, Sauvel C, Dartigues JF. Instrumental activities of daily living as a screening tool for cognitive impairment and dementia in elderly community dwellers. J Am Geriatr Soc. 1992;40:1129–34.
Bier JC, Ventura M, Donckels V, et al. Is the Addenbrooke’s Cognitive Examination effective to detect frontotemporal dementia? J Neurol. 2004;251:428–31.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307–10.
Cacho J, Benito-Leon J, Garcia-Garcia R, Fernandez-Calvo B, Vincente-Villardon JL, Mitchell AJ. Does the combination of the MMSE and Clock Drawing Test (Mini-clock) improve the detection of mild Alzheimer’s disease and mild cognitive impairment? J Alzheimers Dis. 2010;22:889–96.
Chang YL, Bondi MW, McEvoy LK, et al. Global clinical dementia rating of 0.5 in MCI masks variability related to level of function. Neurology. 2011;76:652–9.
Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.
Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Hillsdale, NJ: Lawrence Erlbaum; 1988.
Cohen J. A power primer. Psychol Bull. 1992;112:155–9.
Connon P, Larner AJ. Combining informant (AD8) and patient (MACE) cognitive screening. Poster P0030, Association of British Neurologists Annual Meeting, Liverpool, 3–5 May, 2017.
Cordell CB, Borson S, Boustani M, et al. Medicare Detection of Cognitive Impairment Workgroup. Alzheimer’s Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting. Alzheimers Dement. 2013;9:141–50.
Damian AM, Jacobson SA, Hentz JG, et al. The Montreal Cognitive Assessment and the Mini-Mental State Examination as screening instruments for cognitive impairment: item analyses and threshold scores. Dement Geriatr Cogn Disord. 2011;31:126–31.
De Lepeleire J, Aertgeerts B, Umbach I, et al. The diagnostic value of IADL evaluation in the detection of dementia in general practice. Aging Ment Health. 2004;8:52–7.
De Lepeleire J, Heyrman J, Baro F, Buntinx F. A combination of tests for the diagnosis of dementia had a significant diagnostic value. J Clin Epidemiol. 2005;58:217–25.
Doraiswamy PM, Bieber F, Kaiser L, Krishnan KR, Reuning-Scherer J, Gulanski B. The Alzheimer’s Disease Assessment Scale: patterns and predictors of baseline cognitive performance in multicenter Alzheimer’s disease trials. Neurology. 1997;48:1511–7.
Dos Santos Kawata KH, Hashimoto R, Nishio Y, et al. A validation study of the Japanese version of the Addenbrooke’s Cognitive Examination-Revised. Dement Geriatr Cogn Dis Extra. 2012;2:29–37.
Ferman TJ, Smith GE, Boeve BF, et al. DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging. Neurology. 2004;62:181–7.
Flicker L, Logiudice D, Carlin JB, Ames D. The predictive value of dementia screening instruments in clinical populations. Int J Geriatr Psychiatry. 1997;12:203–9.
Folstein MF, Folstein SE, McHugh PR. “Mini-Mental State.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–98.
Galvin JE, Roe CM, Powlishta KK, et al. The AD8. A brief informant interview to detect dementia. Neurology. 2005;65:559–64.
Galvin JE, Roe CM, Xiong C, Morris JE. Validity and reliability of the AD8 informant interview in dementia. Neurology. 2006;67:1942–8.
Garcia-Caballero A, Garcia-Lado I, Gonzalez-Hermida J, et al. Validation of the Spanish version of the Addenbrooke’s Cognitive Examination in a rural community in Spain. Int J Geriatr Psychiatry. 2006;21:239–45.
Hancock P, Larner AJ. The diagnosis of dementia: diagnostic accuracy of an instrument measuring activities of daily living in a clinic-based population. Dement Geriatr Cogn Disord. 2007;23:133–9.
Hancock P, Larner AJ. Diagnostic utility of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) and its combination with the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in a memory clinic-based population. Int Psychogeriatr. 2009;21:526–30.
Hancock P, Larner AJ. Test Your Memory (TYM) test: diagnostic utility in a memory clinic population. Int J Geriatr Psychiatry. 2011;26:976–80.
Hancock P, Larner AJ. Cornell Scale for Depression in Dementia: clinical utility in a memory clinic. Int J Psychiatry Clin Pract. 2015;19:71–4.
Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med. 2006;25:3443–57.
Hsieh S, Schubert S, Hoon C, Mioshi E, Hodges JR. Validation of the Addenbrooke’s Cognitive Examination III in frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord. 2013;36:242–50.
Juva K, Sulkava R, Erkinjuntti T, Ylikoski R, Valvanee J, Tilvis R. Staging the severity of dementia: comparison of clinical (CDR, DSM-III-R), functional (ADL, IADL) and cognitive (MMSE) scales. Acta Neurol Scand. 1994;90:293–8.
Kalbe E, Kessler J, Calabrese P, et al. DemTect: a new, sensitive cognitive screening test to support the diagnosis of mild cognitive impairment and early dementia. Int J Geriatr Psychiatry. 2004;19:136–43.
Larner AJ. An audit of the Addenbrooke’s Cognitive Examination (ACE) in clinical practice. Int J Geriatr Psychiatry. 2005;20:593–4.
Larner AJ. Addenbrooke’s Cognitive Examination (ACE) for the diagnosis and differential diagnosis of dementia. Clin Neurol Neurosurg. 2007a;109:491–4.
Larner AJ. DemTect: 1-year experience of a neuropsychological screening test for dementia. Age Ageing. 2007b;36:326–7.
Larner AJ. New tests are needed. BMA News. 2007c;19 May:10.
Larner AJ. ACE-R: cross-sectional and longitudinal use for cognitive assessment. In: Fisher A, Hanin I, editors. New trends in Alzheimer and Parkinson related disorders: ADPD 2009. Collection of selected free papers from the 9th International Conference on Alzheimer’s and Parkinson’s disease AD/PD. Prague, Czech Republic, March 11–15, 2009. Bologna: Medimond International Proceedings; 2009. p. 103–7.
Larner AJ. Dementia in clinical practice: a neurological perspective. Studies in the dementia clinic. London: Springer; 2012a.
Larner AJ. Screening utility of the Montreal Cognitive Assessment (MoCA): in place of—or as well as—the MMSE? Int Psychogeriatr. 2012b;24:391–6.
Larner AJ. Mini-Mental Parkinson (MMP) as a dementia screening test: comparison with the Mini-Mental State Examination (MMSE). Curr Aging Sci. 2012c;5:136–9.
Larner AJ. Can the informant Fluctuation Composite Score help in the diagnosis of synucleinopathies? A pragmatic study. Int J Geriatr Psychiatry. 2012d;27:1094–5.
Larner AJ. Addenbrooke’s Cognitive Examination-Revised (ACE-R): pragmatic study of cross-sectional use for assessment of cognitive complaints of unknown aetiology. Int J Geriatr Psychiatry. 2013a;28:547–8.
Larner AJ. Comparing diagnostic accuracy of cognitive screening instruments: a weighted comparison approach. Dement Geriatr Cogn Disord Extra. 2013b;3:60–5.
Larner AJ. Dementia in clinical practice: a neurological perspective. Pragmatic studies in the cognitive function clinic. London: Springer; 2014a.
Larner AJ. Effect size (Cohen’s d) of cognitive screening instruments examined in pragmatic diagnostic accuracy studies. Dement Geriatr Cogn Dis Extra. 2014b;4:236–41.
Larner AJ. Mini-Addenbrooke’s Cognitive Examination: a pragmatic diagnostic accuracy study. Int J Geriatr Psychiatry. 2015a;30:547–8.
Larner AJ. Mini-Addenbrooke’s Cognitive Examination diagnostic accuracy for dementia: reproducibility study. Int J Geriatr Psychiatry. 2015b;30:1103–4.
Larner AJ. AD8 informant questionnaire for cognitive impairment: pragmatic diagnostic test accuracy study. J Geriatr Psychiatry Neurol. 2015c;28:198–202.
Larner AJ. Diagnostic test accuracy studies in dementia. A pragmatic approach. London: Springer; 2015d.
Larner AJ. Optimizing the cutoffs of cognitive screening instruments in pragmatic diagnostic accuracy studies: maximising accuracy or Youden index? Dement Geriatr Cogn Disord. 2015e;39:167–75.
Larner AJ. The Q* index: a useful global measure of dementia screening test accuracy? Dement Geriatr Cogn Dis Extra. 2015f;5:265–70.
Larner AJ. Speed versus accuracy in cognitive assessment when using CSIs. Prog Neurol Psychiatry. 2015g;19(1):21–4.
Larner AJ. Performance-based cognitive screening instruments: an extended analysis of the time versus accuracy trade-off. Diagnostics (Basel). 2015h;5:504–12.
Larner AJ. M-ACE vs. MoCA: a weighted comparison. Int J Geriatr Psychiatry. 2016a;31:1089–90.
Larner AJ. Cognitive screening instruments for the diagnosis of mild cognitive impairment. Prog Neurol Psychiatry. 2016b;20(2):21–6.
Larner AJ. Correlation or limits of agreement? Applying the Bland-Altman approach to the comparison of cognitive screening instruments. Dement Geriatr Cogn Disord. 2016c;42:247–54.
Larner AJ. MACE versus MoCA: equivalence or superiority? Pragmatic diagnostic test accuracy study. Int Psychogeriatr. 2017a;29:931–7.
Larner AJ. Short Montreal Cognitive Assessment: validation and reproducibility. J Geriatr Psychiatry Neurol. 2017b;30:104–8.
Larner AJ. Does combining an informant questionnaire with patient performance scales improve diagnostic test accuracy for cognitive impairment? Int J Geriatr Psychiatry. 2017c;32:466–7.
Larner AJ. Converting cognitive screening instrument test scores to MMSE scores: regression equations. Int J Geriatr Psychiatry. 2017d;32:351–2.
Larner AJ, Hancock P. Does combining cognitive and functional scales facilitate the diagnosis of dementia? Int J Geriatr Psychiatry. 2012;27:547–8.
Larner AJ, Hancock P. ACE-R or MMSE? A weighted comparison. Int J Geriatr Psychiatry. 2014;29:767–8.
Larner AJ, Mitchell AJ. A meta-analysis of the accuracy of the Addenbrooke’s Cognitive Examination (ACE) and the Addenbrooke’s Cognitive Examination-Revised (ACE-R) in the detection of dementia. Int Psychogeriatr. 2014;26:555–63.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179–86.
Lees RA, Hendry BK, Broomfield N, Stott D, Larner AJ, Quinn TJ. Cognitive assessment in stroke: feasibility and test properties using differing approaches to scoring of incomplete items. Int J Geriatr Psychiatry. 2017;32:1072–8.
Mackinnon A, Mulligan R. Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am J Psychiatry. 1998;155:1529–35.
Mackinnon A, Khalilian A, Jorm AF, Korten AE, Christensen H, Mulligan R. Improving screening accuracy for dementia in a community sample by augmenting cognitive testing with informant report. J Clin Epidemiol. 2003;56:358–66.
Mallett S, Halligan S, Thompson M, Collins GS, Altman DG. Interpreting diagnostic accuracy studies for patient care. BMJ. 2012;344:e3999.
Malloy PF, Cummings JL, Coffey CE, et al. Cognitive screening instruments in neuropsychiatry: a report of the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci. 1997;9:189–97.
Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer’s disease and frontotemporal dementia. Neurology. 2000;55:1613–20.
Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR. The Addenbrooke’s Cognitive Examination Revised: a brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry. 2006;21:1078–85.
Mitchell AJ. A meta-analysis of the accuracy of the mini-mental state examination in the detection of dementia and mild cognitive impairment. J Psychiatr Res. 2009;43:411–31.
Mitchell AJ. The Mini-Mental State Examination (MMSE): an update on its diagnostic validity for cognitive disorders. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. London: Springer; 2013. p. 15–46.
Mitchell AJ. The Mini-Mental State Examination (MMSE): update on its diagnostic accuracy and clinical utility for cognitive disorders. In: Larner AJ, editor. Cognitive screening instruments. A practical approach. 2nd ed. London: Springer; 2017. p. 37–48.
Moons KGM, Stijnen T, Michel BC, Büller HR, Van Es GA, Grobbee DE, Habbema DF. Application of treatment thresholds to diagnostic-test evaluation: an alternative to the comparison of areas under receiver operating characteristic curves. Med Decis Making. 1997;17:447–54.
Narasimhalu K, Lee J, Auchus AP, Chen CP. Improving detection of dementia in Asian patients with low education: combining the Mini-Mental State Examination and the Informant Questionnaire on Cognitive Decline in the Elderly. Dement Geriatr Cogn Disord. 2008;25:17–22.
Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, et al. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;53:695–9.
Newman JC, Feldman R. Copyright and open access at the bedside. N Engl J Med. 2011;365:2447–9.
Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for the classification of Alzheimer’s disease, mild cognitive impairment and healthy aging. Alzheimers Dement. 2013;9:529–37.
Shua-Haim J, Koppuzha G, Shua-Haim V, Gross J. A simple score system for clock drawing in patients with Alzheimer’s disease. Am J Alzheimers Dis Other Demen. 1997;12:212–5.
Stokholm J, Vogel A, Johannsen P, Waldemar G. Validation of the Danish Addenbrooke’s Cognitive Examination as a screening test in a memory clinic. Dement Geriatr Cogn Disord. 2009;27:361–5.
van Steenoven I, Aarsland D, Hurtig H, et al. Conversion between mini-mental state examination, Montreal Cognitive Assessment, and Dementia Rating Scale-2 scores in Parkinson’s disease. Mov Disord. 2014;29:1809–15.
Walter SD. Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med. 2002;21:1237–56.
Williamson J, Larner AJ. MACE for diagnosis of dementia and MCI: 3-year pragmatic diagnostic test accuracy study. Dement Geriatr Cogn Disord. 2018;45 in press.
Wojtowicz A, Larner AJ. Diagnostic test accuracy of cognitive screeners in older people. Prog Neurol Psychiatry. 2017;21(1):17–21.
Woodworth RS. Accuracy of voluntary movements. Psychol Rev. 1899;3:1–101.
Yoshida H, Terada S, Honda H, et al. Validation of Addenbrooke’s cognitive examination for detecting early dementia in a Japanese population. Psychiatry Res. 2011;185:211–4.
Yoshida H, Terada S, Honda H, et al. Validation of the revised Addenbrooke’s Cognitive Examination (ACE-R) for detecting mild cognitive impairment and dementia in a Japanese population. Int Psychogeriatr. 2012;24:28–37.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Larner, A.J. (2018). Comparing, Combining and Converting Screening Instruments. In: Dementia in Clinical Practice: A Neurological Perspective. Springer, Cham. https://doi.org/10.1007/978-3-319-75259-4_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-75259-4_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-75258-7
Online ISBN: 978-3-319-75259-4
eBook Packages: MedicineMedicine (R0)